Details of the Drug

General Information of Drug (ID: DMZ5MQM)

Drug Name

GLPG-0555

Synonyms

Chondrocyte differentiation-modulating therapeutics (osteoarthritis), Galapagos/GlaxoSmithKline; GT-622 modulating compounds (osteoarthritis), Galapagos/GlaxoSmithKline

Indication

Disease Entry	ICD 11	Status	REF
Osteoarthritis	FA00-FA05	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0N3YT

References

1	ClinicalTrials.gov (NCT01278095) Oral Bioavailability of GLPG0555 in Different Solid Formulations. U.S. National Institutes of Health.